Does Medicham have positive grading EV?

Based on current pricing, our model estimates a negative grading EV of $0.00 for Medicham — grading costs currently exceed the estimated PSA-10 premium. This is a model estimate based on historical data, not investment advice.

What is the estimated grading EV for Medicham?

Our model estimates approximately 0% return after grading costs, based on historical grade distributions and recent sold comps. Raw price: $9.04, estimated grading cost: ~$22.00, estimated EV: $0.00. Estimates are informational, not investment advice; trading cards are not securities.

Should You Grade Medicham?

Crystal Guardians · #25

Expected-value figures are estimates based on historical grade distributions and market prices. Not a recommendation. Grading outcomes and market prices are not guaranteed. Methodology · Full disclaimer

Estimated grading EV negative

Current grading costs exceed model estimate of PSA 10 premium

Expected Value

Raw price$9.04

Grading cost~$22.00

Blended EV$-3.06

Estimated profit$0.00

Estimated return0%

Break-even sell price$-0.88

Profit by Grade

PSA 7 $19.99 $-11.05 (-36%)

PSA 8 $28.11 $-2.93 (-9%)